Functional diversification of the HD-superfamily; the Hydrolase/Oxygenase Dilemma

HD超家族的功能多样化;

基本信息

  • 批准号:
    9271972
  • 负责人:
  • 金额:
    $ 24.58万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2014
  • 资助国家:
    美国
  • 起止时间:
    2014-09-05 至 2019-04-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): HD-domain proteins constitute a novel superfamily of metalloenzymes that counts presently more than 37,000 members in all three domains of life. Though there are generally annotated as as (phospho)hydrolases their functions are mostly unknown. Less than a decade ago, a novel diiron HD enzyme involved in the catabolism of inositol and associated with type I diabetes mellitus, namely myo-inositol oxygenase was demonstrated to carry out a radically different reaction using molecular oxygen to afford activation of its substrate. The only recently identified HD enzyme PhnZ, was also shown to follow the paradigm of MIOX, employing oxygen for the conversion of an organophosphonate to phosphate by marine microorganisms. The mechanism and structure of the reactive intermediates are presently unknown, but their mechanistic striking similarity to other nonheme Fe enzymes involved in the biosynthesis of antibiotics, invoke questions about the function of these enzymes and their possible implications on human health and environment. For this purpose, the first part of the project will focus on the characterization of PhnZ. This entails a combination of spectroscopic, structural, redox and activity studies so as to establish the modus operandii of such novel oxygenases. The substrate-free and bound forms of the enzyme will be studied so as to obtain for the first time combined structural and electronic information about the 'on' and 'off' reactive states for which crystallographic information has been extremely challenging, how substrate or inhibitors tune and affect the properties of the active site of the enzyme. This information will set the grounds for the discovery of compounds that can activate and inhibit these enzymes, therefore providing powerful control over their function. In addition to, the characterization of downstream events in the chemical reactions will likely establish the common strategy that specific nonheme Fe enzymes (mononuclear or dinuclear) adopt to carry out difficult and environmentally important reactions. The second part of the project aims at mapping the catalytic landscape of (dinuclear) HD domain enzymes, discovery of new functions and identifying the type and the role of metals in modulating specific activities (hydrolysis vs oxygenation). For this purpose, on the basis of phylogenetic analysis new attractive protein targets of unknown function have been identified. Selected protein will be overexpressed and purified. These will be spectroscopically characterized with a combination of EPR, M�ssbauer, crystallographic and NMR techniques. A profile of their activities will be established by screening activities for specific substrates and mass spectrometry methods. Presently there are a handful of HD domain enzymes implicated in immunoresponse, such as restriction factors for HIV-1 or nucleotidases attacking viral nucleotides that have come into the scientific focus. Their function is not completely understood, whereas the presence of one or two metals is not known whether it is functional, structural or co-catalytic. This work will begin during the K99 funding period and will continue during the independent phase and will attempt to study these enzymes and draw the molecular background of their function (hydrolytic vs oxygenation). The long-range purpose of this second phase of the project is to establish on the basis of bioinformatics, crystallographic, mutagenesis and activity studies the determinants directing distinct functions within the HD superfamily that will ultimately lead to the identification new antiviral factors and therapeutic agents as well as the discovery of novel oxygenases implicated in chemically difficult small molecule transformations.
描述(由申请人提供):HD结构域蛋白构成了一个新的金属酶超家族,目前在生命的所有三个结构域中有超过37,000个成员。尽管通常被注释为(磷酸)水解酶,但它们的功能大多未知。不到十年前,一种新的二铁HD酶参与肌醇的催化并与I型糖尿病相关,即肌醇加氧酶,被证明使用分子氧进行完全不同的反应以提供其底物的活化。最近唯一鉴定的HD酶PhnZ也显示出遵循MIOX的范例,利用氧气通过海洋微生物将有机膦酸盐转化为磷酸盐。活性中间体的机制和结构目前尚不清楚,但它们与参与抗生素生物合成的其他非血红素铁酶的机制惊人的相似性,引发了关于这些酶的功能及其对人类健康和环境的可能影响的问题。为此,该项目的第一部分将侧重于PhnZ的表征。这需要结合光谱,结构,氧化还原和活性研究,以建立这种新的加氧酶的工作方式。将研究酶的无底物和结合形式,以便首次获得关于酶的结构和电子信息。 “开”和“关”的反应状态,其中晶体学信息一直是极具挑战性的,底物或抑制剂如何调整和影响酶的活性位点的性质。这些信息将为发现可以激活和抑制这些酶的化合物奠定基础,从而对它们的功能进行有力的控制。此外,化学反应中下游事件的表征将可能建立特定非血红素铁酶(单核或双核)采取的共同策略,以进行困难和对环境重要的反应。该项目的第二部分旨在绘制(双核)HD结构域酶的催化景观,发现新的功能,并确定金属在调节特定活动(水解与氧化)中的类型和作用。为此,在系统发育分析的基础上,已经确定了新的有吸引力的未知功能的蛋白质靶标。选择的蛋白质将被过表达和纯化。这些将用EPR、穆斯堡尔谱、晶体学和NMR技术相结合进行光谱表征。将通过筛选特定底物的活性和质谱法确定其活性概况。目前,有少数HD结构域酶参与免疫应答,如HIV-1的限制因子或攻击病毒核苷酸的核苷酸酶已成为科学焦点。它们的功能尚未完全了解,而一种或两种金属的存在是不知道它是功能性的,结构性的还是共催化性的。这项工作将在K99资助期间开始,并将在独立阶段继续进行,并将尝试研究这些酶,并绘制其功能的分子背景(水解与氧化)。该项目第二阶段的长期目的是在生物信息学、晶体学、诱变和活性研究的基础上建立指导HD超家族内不同功能的决定因素,这将最终导致鉴定新的抗病毒因子, 治疗剂以及涉及化学上困难的小分子转化的新型加氧酶的发现。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Maria-Eirini Pandelia其他文献

Maria-Eirini Pandelia的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Maria-Eirini Pandelia', 18)}}的其他基金

How does a metallocofactor in the Hepatitis B viral protein X orchestrate pathogenesis and liver cancer?
乙型肝炎病毒 X 蛋白中的金属辅因子如何协调发病机制和肝癌?
  • 批准号:
    10389582
  • 财政年份:
    2019
  • 资助金额:
    $ 24.58万
  • 项目类别:
How does a metallocofactor in the Hepatitis B viral protein X orchestrate pathogenesis and liver cancer?
乙型肝炎病毒 X 蛋白中的金属辅因子如何协调发病机制和肝癌?
  • 批准号:
    10170379
  • 财政年份:
    2019
  • 资助金额:
    $ 24.58万
  • 项目类别:
How does a metallocofactor in the Hepatitis B viral protein X orchestrate pathogenesis and liver cancer?
乙型肝炎病毒 X 蛋白中的金属辅因子如何协调发病机制和肝癌?
  • 批准号:
    10428574
  • 财政年份:
    2019
  • 资助金额:
    $ 24.58万
  • 项目类别:
How does a metallofactor in Hepatitis B viral protein X orchestrate pathogenesis and liver cancer
乙型肝炎病毒蛋白 X 中的金属因子如何协调发病机制和肝癌
  • 批准号:
    10798758
  • 财政年份:
    2019
  • 资助金额:
    $ 24.58万
  • 项目类别:
How does a metallocofactor in the Hepatitis B viral protein X orchestrate pathogenesis and liver cancer?
乙型肝炎病毒 X 蛋白中的金属辅因子如何协调发病机制和肝癌?
  • 批准号:
    10642956
  • 财政年份:
    2019
  • 资助金额:
    $ 24.58万
  • 项目类别:
Functional diversification of the HD-superfamily; the Hydrolase/Oxygenase Dilemma
HD超家族的功能多样化;
  • 批准号:
    8921236
  • 财政年份:
    2014
  • 资助金额:
    $ 24.58万
  • 项目类别:
Functional diversification of the HD-superfamily; the Hydrolase/Oxygenase Dilemma
HD超家族的功能多样化;
  • 批准号:
    8767627
  • 财政年份:
    2014
  • 资助金额:
    $ 24.58万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 24.58万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 24.58万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 24.58万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 24.58万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 24.58万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 24.58万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 24.58万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 24.58万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 24.58万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 24.58万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了